✦ LIBER ✦

Melphalan and 5-fluorouracil in advanced gastrointestinal carcinoma: a preliminary report

✍ Scribed by Gough, I.R.; Furnival, C.M.; Burnett, W.

Book ID: 122806603
Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 248 KB
Volume: 6
Category: Article
ISSN: 0305-7372
DOI: 10.1016/S0305-7372(79)80027-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Melphalan, 5-fluorouracil, and medroxypr

Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinoma

✍ MS Piver; SB Lele; B Patsner; LJ Emrich 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Mytomicin-C, cisplatin and fluorouracil

Mytomicin-C, cisplatin and fluorouracil for advanced/recurrent head and neck squamous carcinoma. A preliminary report

✍ Cartel, G.; Lop, A.; Clocchiatti, L.; Sibau, A.; Mansutti, M.; Vigevani, E. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Sequential methotrexate and 5-Fluorourac

Sequential methotrexate and 5-Fluorouracil in advanced ovarian carcinoma

✍ Ross C. Donehower; Neil B. Rosenshein; Jacob Rotmensch; David S. Ettinger 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 469 KB

A combination of 5-fluorouracil and thym

A combination of 5-fluorouracil and thymidine in advanced colorectal carcinoma

✍ Ahud Sternberg; Nicholas J. Petrelli; Jesse Au; Youcef Rustum; Arnold Mittelman; 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 457 KB

Concurrent administration of thymidine (TdR) has been shown to increase the antitumor activity of 5-fluorouracil (5-FU) in various experimental models. The clinical response rate, side-effects, and toxicity of 5-FU and TdR were evaluated in 27 patients with advanced colorectal carcinomas. Each 6-day

Preliminary report on the efficacy of se

Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer

✍ Alan M. Gewirtz; Ed Cadman 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

Recent in vitro and animal tumor studies suggest that sequential methotrexate (MTX) and 5-fluorouracil (5-FU) may be much more tumoricidal than either drug when used alone or in conventional combinations. Seventeen evaluable female patients with advanced carcinoma of the breast were treated with MTX

Adriamycin, CCNU, and 5-fluorouracil in

Adriamycin, CCNU, and 5-fluorouracil in patients with advanced gastrointestinal cancer

✍ Bjöurn J. Cedermark; Peter Cunven; Gary Hammarberg 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

## Abstract Forty‐one patients with measurable advanced gastrointestinal malignancy were treated with a combination of Adriamycin (doxorubicin), 5‐FU (5‐fluorouracil), and CCNU (1‐(2‐chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea). The response to therapy was evaluated every eight weeks. In addition to st